Jim Cramer recommends following Can-Fite Biopharma

13-01-2014 GlobesComments (0)

Can-Fite BioPharmaPharmaceutical

Can-Fite BioPharma Ltd. (TASE:CFBI; NYSE MKT: CANF) has obtained a recommendation from an unexpected direction: American stock guru Jim Cramer of CNBC recommended the share in his review "5 Under-$10 Biotech Stocks to Watch.".

Read more on Globes

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top